Is parenteral hydration beneficial in terminally ill cancer patients?

Medwave
José Canihuante, Pedro Pérez

Abstract

It is common for terminally ill patients to have a reduced fluid intake, which often results in a need for more medical support. However, it is not clear if this measure has a real clinical impact. To answer this question we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We extracted data from the systematic reviews, reanalyzed data from primary studies and generated a summary of findings table using the GRADE approach. We identified four systematic reviews including 51 studies overall, from which three were randomized trials. We concluded the administration of parenteral hydration might make little or no difference in terms of survival and quality of life in terminally ill cancer patients, and that it is not clear whether it has any other benefit because the certainty of the evidence is very low.

References

Jul 1, 1994·Journal of Pain and Symptom Management·R L FainsingerJ Hanson
Mar 1, 1996·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·E BrueraR L Fainsinger
May 28, 1998·Journal of Pain and Symptom Management·E BrueraS Watanabe
Jan 27, 1999·Journal of Pain and Symptom Management·J J FinsB D Rapkin
Feb 8, 2000·The American Journal of Hospice & Palliative Care·T MoritaS Chihara
Feb 11, 2000·Archives of Internal Medicine·J H GroenewoudP J van der Maas
Jul 14, 2000·Journal of the American Geriatrics Society·M DasguptaP A Rochon
Nov 2, 2002·International Journal of Palliative Nursing·L CerchiettiF Palazzo
Nov 19, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·T-Y ChiuC-Y Chen
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tatsuya MoritaUNKNOWN Japan Palliative Oncology Study Group
Oct 1, 2003·Journal of Palliative Medicine·Tatsuya MoritaSatoshi Inoue
Nov 19, 2003·Journal of Palliative Medicine·Susan Elaine McClementMichael Steven Harlos
Jan 22, 2004·Journal of Palliative Medicine·Joseph W ShegaGreg A Sachs
Jan 22, 2004·Journal of Palliative Medicine·J Ferraz GonçalvesAlexandra Silva
Jun 24, 2004·Journal of the American Geriatrics Society·Joseph W ShegaCarol B Stocking
Nov 24, 2004·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Ylva OrrevallJohan Permert
Feb 3, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T MoritaUNKNOWN Japan Palliative Oncology Study Group
Mar 2, 2005·Archives of Internal Medicine·Georg BosshardUNKNOWN European End-of-Life Consortium
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eduardo BrueraJ Lynn Palmer
Apr 23, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A-M StevensJ Hardy
Nov 1, 2005·Journal of Pain and Symptom Management·Sebastiano MercadanteAlessandra Casuccio
Jan 25, 2006·Journal of Palliative Medicine·Yuichiro MasudaKazumasa Uemura
Feb 21, 2006·Journal of Pain and Symptom Management·Tatsuya MoritaUNKNOWN Japan Palliative Oncology Study Group
Nov 15, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Do Youn OhNoe Kyeong Kim
Jun 2, 2007·Intensive Care Medicine·Charles L SprungUNKNOWN Ethicus Study Group
Jul 4, 2007·Journal of Pain and Symptom Management·Hilde M BuitingUNKNOWN EURELD-Consortium
Oct 6, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kazuki SatoYosuke Uchitomi
Apr 17, 2008·International Journal of Palliative Nursing·Pamela van der RietLudmilla Sneesby
May 28, 2008·Journal of Advanced Nursing·Els BryonBernadette Dierckx de Casterlé
Nov 5, 2008·Journal of Palliative Medicine·Laura C HansonTimothy S Carey
Jan 5, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N J H RaijmakersUNKNOWN OPCARE9
Nov 22, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eduardo BrueraKenneth Tarleton
Apr 25, 2014·The Cochrane Database of Systematic Reviews·Phillip GoodJane Stephens

❮ Previous
Next ❯

Citations

Oct 4, 2020·Current Opinion in Supportive and Palliative Care·Yi L Hwa, Michelle R Kull

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.